Daclizumab - Drug Information
Generic Name : Daclizumab
Pronunciation : (da-kliz-uh-mab)
ICD Code : Y43.4 | Therapeutic Classification : Immunosuppressants
Trade Name(s) :
International - Zenapax.
Why is Daclizumab Prescribed? (Indications)
This medication is an immunosuppressive agent, prescribed for acute organ rejection during kidney transplantation.
When should Daclizumab not to be taken? (Contraindications)
Hypersensitivity.
What is the dosage of Daclizumab?
IV- The recommended dose in adult and pediatric patients is 1mg/kg.
How should Daclizumab be taken?
It comes as a solution for injection to be administered by a health care provider into the vein.
What are the warnings and precautions for Daclizumab?
* Caution should be exercised in patients with any allergy, during pregnancy and breastfeeding.* It may cause dizziness or blurred vision, do not drive a car or operate machinery while taking this medication.
* It may affect blood sugar level; monitor sugar level regularly while taking this medication.
What are the side effects of Daclizumab?
Gastrointestinal - Constipation, nausea, diarrhea, vomiting, abdominal pain, indigestion, abdominal distention and abdominal pain.Metabolic - Swelling in the extremities.
Central Nervous System - Tremor, headache, sleeplessness and dizziness.
Genitourinary - Painful urination and kidney damage.
Body as a Whole - Post-traumatic pain, chest pain, fever, pain and fatigue.
Heart - High blood pressure and fast heart rate.
Respiratory - Difficulty in breathing, lung swelling and increased cough.
Skin - Impaired wound healing without infection and pimples.
Musculoskeletal - Musculoskeletal pain and back pain.
Blood - Decrease in platelet count and bleeding disorders.